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Abstract. An efficient and environmentally adapted synthesis of polysubstituted imidazoles in one-pot and 
multicomponent reaction of various aldehydes, benzil, aliphatic and aromatic primary amines and ammo-
nium acetate under solvent-free condition is reported. Highly efficient role of Y(NO3)3 ×6H2O as catalyst 
in this synthesis was shown. By this advantage, several polysubstituted imidazoles as pharmaceutical im-
portant molecules can be prepared in high yield and high purity. This method is very easy and rapid for 
the synthesis of imidazole derivatives. All products were deduced from their IR and NMR spectroscopic 
and elemental analysis data. The catalyst exhibited remarkable reusable activity. (doi: 10.5562/cca1979)  
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INTRODUCTION 
Multicomponent reactions (MCRs) are the special type 
of organic reactions which afford complex products 
from reaction of three or more simple starting materials 
in one pot. Because of atom-economy, convergent char-
acter, operational simplicity, structural diversity and 
complexity of the molecules in these reactions, they 
have attracted much attention.1,2 
The imidazoles and their derivatives are very im-
portant molecules because many applications in chemi-
cal processes, especially in pharmaceuticals.3,4 Various 
substituted imidazoles act as inhibitors of p38 MAP  
kinase,5 B-Raf kinase,6 glucagon receptors,7 plant growth 
regulators,8 antitumor9 and pesticides.10 
There are many methods for the synthesis of 
polysubstituted imidazoles such as condensation of 
diones, aldehydes, primary amines and ammonia in the 
presence of various acid catalysts,11–13 N-alkylation of 
trisubstituted imidazoles,14 condensation of benzil or 
benzoin acetate with aldehydes, primary amines and 
ammonia in the presence of copper acetate15,16 etc. The 
first mention method is the most well-known and classi-
cal method. 
However, some of these methods, involved long 
reaction times, and unsatisfactory yields. Therefore, 
improvements in these syntheses have been sought 
continuously. In this work, high activation, and reusabil-
ity of Y(NO3)3×6H2O as a catalyst in the synthesis of 
polysubstituted imidazoles have been shown. 
A new method for the synthesis of polysubstituted 
imidazoles was obtained by condensation of benzil with 
aldehydes, primary amines and ammonium acetate in 
the presence of Y(NO3)3×6H2O as an effective catalyst 
in solvent free condition (Scheme 1).  
Herein, we report a simple, rapid and one-pot pro-
cedure for the synthesis of three and four substituted 
imidazoles by using Y(NO3)3×6H2O with high yields 
and short reaction times. While using benzil 1, aromatic 
aldehydes 2, aromatic and aliphatic amine 3, ammonium 
acetate 4 and Y(NO3)3×6H2O as catalyst under solvent-
free condition lead to tetrasubstituted imidazoles 5, that 
in the absence of aromatic and aliphatic amine 3, 
trisubstituted imidazoles 6 were obtained (Scheme 1). 
 
EXPERIMENTAL SECTION 
Melting points were measured on an elecrtothermal 
KSB1N apparatus. IR spectra were recorded in the ma-
trix of KBr with JASCO FT-IR-680 plus spectrometer. 
1H NMR and 13C NMR spectra were recorded on a FT-
NMR Bruker Avance Ultra Shield Spectrometer at 
400.13 and 100.62 MHz in CDCl3 and DMSO-d6 as 
solvent in the presence of tetramethylsilane as internal 
standard. TLC was performed on TLC-Grade silica gel-
G/UV 254 nm plates. The products were isolated and 
characterized by physical and spectral data and they 
were compared with authentic samples (Table 1). 
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Table 1. Synthesis of polysubstituted imidazoles catalyzed by Y(NO3)3 ×6H2O 
Compound R1 R2 t / min Yield(a) / % M.p. / °C 
(from literature)
5a C6H5 C6H5CH2 30 96 162–164 (Ref. 13)
5b 4-BrC6H4 C6H5CH2 25 90 169–170 (Ref. 13)
5c 4-CH3C6H4 C6H5CH2 55 98 156–158 (Ref. 17)
5d 4-ClC6H4 C6H5CH2 60 85 160–162 (Ref. 17)
5e 2-ClC6H4 C6H5CH2 25 85 193–195 (Ref. 18)
5f 3-NO2C6H4 C6H5CH2 20 80 150–152
(b) 
5g 4-CH3C6H4 Cyclohexyl 40 75 160–161 (Refs. 19,20)
5h 4-OCH3C6H4 C6H5CH2 50 90 148–151 (Ref. 21)
5i 2-OH-5-BrC6H3 4-ClC6H4 25 98 156–158
(b) 
5j 4-Benzyloxyphenyl C6H5CH2 95 96 138–139
(b) 
5k 2,4-Dichlorophenyl C6H5CH2 45 95 216–219
(b) 
5l 4-CH3C6H4 C6H5 25 93 182–184 (Ref. 20)
6a C6H5 – 50 90 272–273 (Ref. 22)
6b 3-BrC6H4 – 10 89 120–122 (Ref. 23)
6c 2-OHC6H4 – 30 90 209–211 (Ref. 24)
6d 2-OCH3C6H4 – 25 92 204–206 (Ref. 21)
6e 4-OCH3C6H4 – 100 70 227–230 (Ref. 22)
6f 4-Benzyloxyphenyl – 60 68 235–236 (Ref. 25) (c)
6g 2-Fluorenyle – 35 97 283–286(b) 
6h 3-Indolyl – 140 83 311–313(b) 
6i 4-ClC6H4 – 25 90 257–259 (Ref. 26)
6j 3-NO2C6H4 – 10 91 308–309 (Ref. 27)
(a) Refers to isolated yields. 
(b) Novel compound. 
(c) Melting point of this compound was not reported by author. 
 
Scheme 1. Synthesis of polysubstituted imidazoles in the presence of Y(NO3)3 ×6H2O as catalyst. 
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General Procedure for Synthesis of 1,2,4,5-Tetrasub-
stituted Imidazoles by Y(NO3)3 × 6H2O 
A mixture of aromatic aldehyde (1 mmol), benzil (1 
mmol), primary amine (1 mmol), ammonium acetate (1 
mmol) and Y(NO3)3×6H2O (mole ratio, r = 15 %) were 
stirred at 140 °C in solvent-free condition. The progress 
of reaction was monitored by TLC. After completion of 
reaction, the mixture was coolled to room temperature 
and was solved in 50 mL water then was filtered. Ob-
tained products were purified by crystallization from 
acetone-water mixture (V(acetone) : V(water) =10 : 1). 
The products were characterized by IR, NMR, and 
through comparison of their physical properties with 
those reported in literature.13,17–27 
Hence, general procedure for the synthesis of 
2,4,5-trisubstituted imidazoles is same to the 1,2,4,5-
tetrasubstituted imidazoles, but it needs to 10 % of cata-
lyst, 2 mmol of ammonium acetate instead of 1 mmol in 
the absence of primary amine. 
 
Representative Spectral Data 
1-Benzyl-2,4,5-triphenyl-1H-imidazole (5a) 
M.p. 162–164 °C (Ref. 13) 163–165 °C; IR (KBr) maxν /  
cm–1: 3061, 3026, 2308, 1601, 1521, 1497, 1350, 761, 
696. 1H NMR (250 MHz, DMSO-d6) δ / ppm: 5.13 (s, 
2H), 7.18–8.41 (m, 20H). 13CNMR (62.69 MHz, DMSO-
d6) δ / ppm: 48.29, 126.00, 126.38, 126.81, 128.11, 
129.08, 129.58, 129.90, 130.09, 130.98, 131.09, 135.09, 




M.p. 169–170 °C (Ref. 13) 170–172 °C; IR (KBr) maxν / 
cm–1: 3059, 3027, 2938, 1599, 1479, 1358, 1070, 835, 
758, 694. 1H NMR (400.13 MHz, DMSO-d6) δ / ppm: 
4.86 (s, 2H), 6.61–7.46 (m, 19H). 13CNMR (100.62 
MHz, DMSO-d6) δ / ppm: 49.41, 125.86, 126.51, 
126.78, 127.53, 128.14, 128.25, 128.74, 128.87, 130.48, 
130.79, 131.03, 131.79, 137.33. 
 
1-Benzyl-4,5-diphenyl-2-p-tolyl-1H-imidazole (5c) 
M.p. 156–158 °C (Ref. 17) 156–157 °C; IR (KBr) maxν / 
cm–1: 3060, 3027, 2926, 1600, 1496, 1349, 826, 767, 
694. 1HNMR (400.13 MHz, DMSO-d6) δ / ppm: 2.08 (s, 
3H), 4.91 (s, 2H), 6.61–7.40 (m, 19H). 13CNMR (100.62 
MHz, DMSO-d6) δ / ppm: 22.52, 49.41, 127.15, 127.47, 
127.94, 128.46, 129.22, 129.72, 129.92, 130.10, 130.45, 




M.p. 160–162 °C (Ref. 17) 157–158 °C; IR (KBr) maxν / 
cm–1: 3059, 3029, 2936, 1600, 1480, 1357, 1089, 835, 
758, 693. 1HNMR (400.13 MHz, DMSO-d6) δ / ppm: 
4.9 (s, 2H), 6.60–7.50 (m, 19H). 13CNMR (100.62 MHz, 
DMSO-d6) δ / ppm: 48.31, 125.88, 126.55, 127.54, 
129.13, 129.31, 130.28, 130.43, 130.74, 131.04, 134.18, 




M.p. 139–140 °C (Ref. 18) 140–142 °C; IR (KBr) maxν /  
cm–1: 3062, 3026, 2930, 1602, 1485, 1349, 1079, 758, 
690. 1HNMR (400.13 MHz, DMSO-d6) δ / ppm: 4.74 (s, 
2H), 6.42–7.42 (m, 19H). 13CNMR (100.62 MHz, 
DMSO-d6) δ / ppm: 43.17, 126.00, 126.50, 126.68, 
127.48, 128.44, 128.69, 128.99, 129.15, 129.36, 129.74, 
129.81, 130.33, 130.61, 130.89, 131.08, 131.15, 132.92, 




M.p. 150–152 °C; IR (KBr) maxν /cm
–1: 3061, 3026, 
2308, 1601, 1521, 1497, 1350, 810, 730, 696. 1H NMR 
(400.13 MHz, DMSO-d6) δ / ppm: 5.19(s, 2H), 6.89 (d, 
J = 6.15 Hz, 2H), 7.21–7.63 (m, 14H), 8.04 (d, J =  
7.8 Hz, 1H), 8.23 (d, J = 7.8 Hz, 1H), 8.57 (s, 1H). 
13CNMR (100.62 MHz, DMSO-d6) δ/ppm: 47.42,  
122.30, 122.59, 124.71, 125.67, 125.73, 126.71, 127.15,  
127.84, 127.97, 128.56, 129.36, 129.93, 130.24, 131.57,  
132.98, 133.51, 135.78, 144.23, 147.20. Anal. Calcd. 
mass fractions of elements, w / %, for C28H21N3O2 
(Mr = 431.49): C 77.94, H 4.91, N 9.74. Found: C 77.87, 
H 4.83, N 9.62. 
 
1-Cyclohexyl-4,5-diphenyl-2-p-tolyl-1H-imidazole (5g) 
M.p. 160–161 °C (Ref. 20) 162–164 °C; IR (KBr) maxν /  
cm–1: 3058, 3020, 2930, 1600, 1495, 1349, 825, 766, 
695. 1HNMR (400.13 MHz, CDCl3) δ / ppm: 0.95 (m, 
2H), 1.35–1.55 (m, 6H), 1.75 (m, 2H), 2.35 (s, 3H), 
3.80–3.97 (m, 1H), 6.70–7.45 (m, 14H). 13CNMR 
(100.62 MHz, CDCl3) δ / ppm: 21.45, 25.12, 26.21, 
33.59, 58.31, 125.94, 126.01, 126.68, 127.60, 127.89, 
127.97, 128.18, 128.65, 128.76, 128.89, 129.01, 129.04, 





M.p. 163–166 °C (Ref. 21) 164–165 °C; IR (KBr) maxν /  
cm–1: 3063, 3019, 2295, 1609, 1519, 1493, 1354, 696. 
1H NMR (400.13 MHz, CDCl3) δ / ppm: 3.81 (s, 3H), 
5.08 (s, 2H), 6.82–7.56 (m, 15H), 7.58 (d, J = 2.3 Hz, 
4H). 13CNMR (100.62 MHz, CDCl3) δ / ppm: 47.16, 
54.26, 112.95, 122.40, 124.94, 125.21, 125.71, 126.26, 
127.00, 127.49, 127.52, 127.71, 128.02, 128.70, 129.37, 




M.p. 156–158 °C; IR (KBr) maxν /cm
–1: 3458, 3063, 
1659, 1593, 1578, 1211, 1174, 1096. 1HNMR (400.13 
MHz, DMSO-d6) δ/ppm: 6.92–8.53 (m, 17H), 13.06 (s, 
1H). 13CNMR (100.62 MHz, DMSO-d6) δ /ppm: 115.17, 
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123.92, 125.53, 127.64, 134.31, 137.31, 139.26, 140.54, 
151.31, 164.74, 166.94. Anal. Calcd. mass fractions of 
elements, w / %, for C27H18BrClN2O (Mr = 501.80): C 




M.p. 138–139 °C; IR (KBr) maxν /cm
–1: 2857, 1601, 
1575, 1526, 1289, 1247, 1177. 1HNMR (400.13 MHz, 
DMSO-d6) δ / ppm: 2.18 (s, 2H), 5.06 (s, 2H), 6.83–7.82 
(m, 24H). 13CNMR (100.62 MHz, DMSO-d6) δ / ppm: 
48.29, 70.03, 115.05, 123.79, 126.06, 126.38, 126.85, 
127.41, 127.53, 128.11, 128.16, 128.68, 128.86, 129.89, 
130.50, 131.14, 131.23, 134.70, 136.76, 137.75, 137.94, 
148.02, 159.33. Anal. Calcd. mass fractions of elements, 
w / %, for C35H28N2O (Mr = 492.61): C 85.34, H 5.73, N 




M.p. 216–219 °C; IR (KBr) maxν /cm
–1: 3069, 2924, 
1557, 1523, 1459, 1092. 1HNMR (400.13 MHz, DMSO-
d6) δ / ppm: 2.18 (s, 2H), 7.45–8.41 (m, 13H), 8.64 (d, J 
= 7.6 Hz, 1H), 8.77 (t, J = 8.4 Hz, 2H). 13CNMR 
(100.62 MHz, DMSO-d6) δ / ppm: 120.88, 121.13, 
122.98, 123.47, 123.76, 125.00, 126.03, 126.82, 127.20, 
127.39, 127.43, 127.56, 129.00, 129.58, 131.28, 132.31, 
133.77, 135.20, 136.93, 145.22. Anal. Calcd. mass frac-
tions of elements, w / %, for C28H20Cl2N2 (Mr = 455.38): 
C 73.85, H 4.43, N 6.15. Found: C 73.71, H 4.36, N 6.09. 
 
1,4,5-Triphenyl-2-p-tolyl-1H-imidazole (5l) 
M.p. 182–184 °C (Ref. 20) 185–188 °C; IR (KBr) maxν /  
cm–1: 3055, 3022, 2930, 1600, 1495, 1349, 826, 767, 
694. 1H NMR (400.13 MHz, CDCl3) δ / ppm: 2.34 (s, 
3H), 7.07–7.36 (m, 17H), 7.64 (d, J = 7.1 Hz, 2H). 
13CNMR (100.62 MHz, CDCl3) δ / ppm: 20.23, 124.24, 
125.49, 126.39, 126.67, 126.85, 127.09, 127.12, 127.27, 
127.45, 127.77, 127.79, 127.98, 128.46, 129.74, 130.11, 
136.23, 137.10, 146.06. 
 
2-(3-Bromophenyl)-4,5-diphenyl-1H-imidazole (6b) 
M.p. 120–122 °C (Ref. 23) 118–122 °C; IR (KBr) maxν /  
cm–1: 3387, 3062, 1584, 1529, 1480, 1241, 1100. 
1HNMR (400.13 MHz, CDCl3) δ / ppm: 7.26–7.78 (m, 
14H), 9.40 (s, 1H). 13CNMR (100.62 MHz, CDCl3) 
δ / ppm: 121.86, 125.62, 126.02, 126.75, 127.41, 127.70, 
127.76, 128.11, 131.05. 
 
2-(2-Hydroxyphenyl)-4,5-diphenyl-1H-imidazole (6c) 
M.p. 209–211 °C (Ref. 24) 209–210 °C; IR (KBr) maxν /  
cm–1: 3450, 3385, 1584, 1529, 1480, 1240, 1098. 
1HNMR (400.13 MHz, CDCl3) δ / ppm: 6.92 (d, J = 
7.28 Hz, 1H), 7.08 (d, J = 7.7 Hz, 1H), 7.26–7.62 (m, 
12H), 9.36 (s, 1H), 12.83 (s, 1H). 13CNMR (100.62 
MHz, CDCl3) δ / ppm: 111.39, 116.80, 117.92, 122.00, 
126.32, 127.14, 127.38, 128.07, 129.54, 144.67, 156.45. 
2-(2-Methoxyphenyl)-4,5-diphenyl-1H-imidazole (6d) 
M.p. 204–206 °C (Ref. 24) 210–211 °C; IR (KBr) maxν /  
cm–1: 3388, 3062, 2933, 1584, 1530, 1481, 1240, 1099. 
1HNMR (400.13 MHz, DMSO-d6) δ / ppm: 4.05 (s, 3H), 
7.03–7.69 (m, 13H), 8.50 (d, J = 8 Hz, 1H), 10.51 (s, 
1H). 13CNMR (100.62 MHz, DMSO-d6) δ / ppm: 
126.45, 126.83, 127.33, 128.22, 128.59, 129.07, 129.67, 
129.91, 130.26, 131.02, 132.98, 133.97. 
 
2-(4-Methoxyphenyl)-4,5-diphenyl-1H-imidazole (6e) 
M.p. 227–230 °C (Ref. 22) 228–230 °C; IR (KBr) maxν /  
cm–1: 3433, 3027, 1613, 1578, 1542, 1248, 1176. 
1HNMR (400.13 MHz, DMSO-d6) δ / ppm: 3.87 (s, 3H), 
6.98–7.86 (m, 10H), 7.55 (s, 2H), 7.85 (d, J = 8.4 Hz, 
2H), 9.23 (s, 1H). 13CNMR (100.62 MHz, DMSO-d6) 
δ / ppm: 55.36, 114.27, 122.78, 126.78, 127.30, 127.80, 
128.55, 146.14, 160.16. 
 
2-(4-Benzyloxyphenyl)-4,5-diphenyl-1H-imidazole (6f) 
M.p. 235–236 °C (Ref. 25); IR (KBr) maxν /cm
–1: 3054, 
3018, 2930, 1608, 1578, 1541, 1230, 1181. 1HNMR 
(400.13 MHZ, DMSO-d6) δ / ppm: 5.16 (s, 2H), 7.11–
7.54 (m, 17H), 8.01 (d, J = 8.8 Hz, 2H), 12.51 (s, 1H). 
13CNMR (100.62 MHz, DMSO-d6) δ / ppm: 69.78, 
115.42, 123.82, 126.09, 127.18, 127.52, 128.26, 128.36, 




M.p. 283–286 °C; IR (KBr) maxν /cm
–1: 3350, 3054, 
2950, 1601, 1532, 1500. 1HNMR (400.13 MHz, DMSO-
d6) δ / ppm: 4.01 (s, 2H), 7.33–8.00 (m, 15H), 8.130 (d, 
J = 7.6 Hz, 1H), 8.32 (s, 1H), 12.733 (s, 1H). 13CNMR 
(100.62 MHz, DMSO-d6) δ / ppm: 39.92, 120.36, 
120.68, 122.37, 124.57, 125.64, 126.73, 127.42, 128.28, 
128.90, 129.36, 141.23, 141.63, 143.88, 143.95, 146.42. 
Anal. Calcd. mass fractions of elements, w / %, for 
C28H20N2 (Mr = 384.47): C 87.47, H 5.24, N 7.29. 
Found: C 87.41, H 5.29, N 7.22. 
 
3-Indolyl-4,5-diphenyl-1H-imidazole (6h) 
M.p. 311–313 °C; IR (KBr) maxν /cm
–1: 3413, 3055, 
1598, 1490, 1451. 1HNMR (400.13 MHZ, DMSO-d6) 
δ / ppm: 7.128–7.587 (m, 13H), 8.006 (d, J = 2.4 Hz, 
1H), 8.462 (d, J = 7.2 Hz, 1H), 11.404 (s, 1H), 12.4  
(s, 1H). 13CNMR (100.62 MHz, DMSO-d6) δ / ppm: 
106.95, 112.13, 120.24, 121.92, 122.40, 124.53, 125.51, 
127.36, 128.05, 128.92, 136.75, 144.11. Anal. Calcd. 
mass fractions of elements, w / %, for C23H17N3 
(Mr = 335.40): C 82.36, H 5.11, N 12.53. Found: C 
82.29, H 5.21, N 12.40. 
 
2-(4-Chlorophenyl)-4,5-diphenyl-1H-imidazole (6i) 
M.p. 257–259 °C (Ref. 26) 257–260 °C; IR (KBr) maxν /  
cm–1: 3386, 3062, 1584, 1529, 1481, 1240, 1099. 
1HNMR (400.13 MHZ, CDCl3) δ / ppm: 6.99–7.36 (m, 
12H), 7.86 (d, J = 7 Hz, 2H), 12.09 (s, 1H). 13CNMR 
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(100.62 MHz, CDCl3) δ / ppm: 125.94, 126.72, 127.39, 
127.68, 128.24, 132.70, 144.31. 
 
2-(3-Nitrophenyl)-4,5-diphenyl-1H-imidazole (6j) 
M.p. 308–309 °C (Ref. 27) >295 °C; IR (KBr) maxν /  
cm–1: 3380, 3065, 1580, 1527, 1479, 1239, 1099, 810, 
758. 1HNMR (400.13 MHZ, DMSO-d6) δ / ppm: 7.30–
7.53 (m, 10H), 7.78 (t, J = 8 Hz, 1H), 8.51 (d, J = 8 Hz, 
1H), 8.95 (t, J = 1.8 Hz, 1H), 9.41 (d, J = 8 Hz, 1H), 
13.10 (s, 1H), 13CNMR (100.62 MHz, DMSO-d6) 
δ / ppm: 119.40, 122.61, 127.13, 128.44, 128.68, 130.44, 
131.17, 131.82, 143.38, 148.37. 
 
RESULTS AND DISCUSSION 
Firstly, synthesis of 1-benzyl-2,4,5-triphenyl imidazoles 
was chosen as a model reaction (compound 5a) in the 
synthesis of polysubstituted imidazoles to determine the 
optimum condition for this synthesis. In model reaction, 
in the presence of Y(NO3)3×6H2O (15 %) as catalyst, 
the mixture of benzil (1 mmol), benzaldehyde (1 mmol), 
ammonium acetate (1 mmol), benzylamine (1 mmol) 
carried out in different solvents such as water, ethanol, 
methanol, chloroform, acetonitrile and solvent-free 
conditions. From these experiments, it was clearly 
demonstrated that the solvent-free conditions offer the 
best conditions to accomplish this synthesis (Table 2). 
Carrying out the model reaction in the absence of 
catalyst at solvent-free conditions and room temperature 
for 24 h lead to a very poor yield (12 %) of the product. 
In the absence of catalyst for enhance the yield of the 
desired product, temperature of the reaction was in-
creased to 200 °C, but no appreciable increment in the 
product yield was observed. Therefore, we found that 
the presence of the catalytic amount of Y(NO3)3×6H2O 
and solvent-free condition are the best conditions for 
this synthesis.  
We also evaluated quantity of required catalyst in 
synthesis of tetrasubstituted imidazoles for model reac-
tion (compound 5a). It was found that maximum yield 
(96 %) obtained, when the reaction was carried out with 
15 % of Y(NO3)3×6H2O, but for the synthesis of 2,4,5-
trisubtitutedimidazoles, the best amount of the catalyst 
was found 10 % of catalyst, when the reaction between 
benzil 1 (1 mmol), aromatic aldehydes 2 (1 mmol) and 
ammonium acetate 4 (2 mmol) was chosen as a model 
reaction (Table 3). 
We also examined the model reactions at various 
temperatures to find out its effect on the progress of the 
Table 2. The effect of solvents in synthesis of polysubstituted 
imidazoles for model reaction 
Solvent t / min Yield / % 
Water 90 46 
Ethanol 35 75 
Methanol 40 78 
Chloroform 120 49 
Acetonitrile 80 73 
Solvent-free 30 96 
 
Table 4. Optimization of temperature for model reaction 
ϑ / °C 
Trisubstituted imidazole  Tetrasubstituted imidazole 
t / min Yield / %  t / min Yield / % 
80 225 70  180 65 
100 160 85  110 80 
120 100 85  80 85 
140 50 90  30 96 
160 60 88  40 90 
 
Table 3. Optimization of mole ratio of the catalyst in synthesis of tri and tetrasubstituted imidazoles 
Mole ratio of 
Y(NO3)3 × 6H2O / % 
Trisubstituted imidazole  Tetrasubstituted imidazole 
t / min Yield / %  t / min Yield / % 
0.5 110 75  120 50 
1 90 80  110 60 
5 60 88  60 80 
10 50 90  40 90 
15 50 90  30 96 
20 40 90  25 80 
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reaction in the presence of optimized amount of catalyst 
(Table 4). The maximum rate of reaction was obtained 
at 140 °C as the optimum temperature for tri and tetra-
substituted imidazoles.  
As can be concluded from Table 4, the reaction 
proceeded slowly at 80 °C. With increasing temperature 
to 140 °C, reaction yield was increased and time of 
reaction was decreased, when the reaction was heated 
above 140 °C, so high temperatures did not further 
improved yield and decrease time of reaction.  
According to the archived optimal condition, we 
conducted the synthesis of polysubstituted imidazoles in 
the presence of Y(NO3)3×6H2O as catalyst in solvent-
free condition at 140 °C. 
 
Reusability of the Catalyst 
At the end of the reaction, the catalyst was filtered, 
washed with diethyl ether, dried at 130 °C for 1 h,  
and reused in another reaction. We found that 
Y(NO3)3×6H2O showed high catalytic activity. Moreo-
ver, it can be recovered and reused several times with-
out significant loss of activity. The results of these ob-
servations for the model reaction are shown in Table 5. 
A probable mechanism for the synthesis of 
tetrasubstituted imidazoles may be postulated as shown 
below (Scheme 2). 
As can be seen in Scheme 2, Y(NO3)3×6H2O is a 
Lewis acid so that it can activated the carbonyl group of 
aldehydes 2 to decrease the energy of transition state. 
Then nucleophilic attack of amine 3 on the activated 
carbonyl of aldehydes, resulted to the formation of 
imine, and it followed by nucleophilic attack of the 
insitu generated ammonia from 4 to the imine, giving 
the intermediate 7. From condensation of intermediate 7 
with benzil 1 and dehydration of it, corresponding 
imidazoles 5 are produced. 
The probable mechanism for synthesis of 
trisubstituted imidazoles is the same (amine was substi-
tuted with ammonium acetate). 
 
Scheme 2. The suggested mechanism for synthesis of tetrasubstituted imidazoles. 
Table 5. Reusability results of Y(NO3)3 ×6H2O on the reaction 
process for the model reaction 
Total reusability t / min Yield / % 
1 30 96 
2 30 95 
3 35 95 
4 45 97 
5 55 97 
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CONCLUSION 
In this work, we found a thermal exposure synthetic 
method of polysubstituted imidazoles, that it is a simple, 
efficient and green chemistry via multicomponent one-
pot reaction in the presence of Y(NO3)3×6H2O as an 
inexpensive and eco-friendly catalyst in solvent-free 
condition. Products were isolated in excellent yields, 
and the catalyst efficiently recovered and reused. That is 
considered as economic advantages of this synthesis. It 
is believed that this procedure will find important appli-
cations in the synthesis of wide range of polysubstituted 
imidazoles. 
Supplementary Materials. – Supporting informations to the 
paper are enclosed to the electronic version of the article. 
These data can be found on the website of Croatica Chemica 
Acta (http://public.carnet.hr/ccacaa).  
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